Safety and efficacy study of MRE0094 to treat chronic, neuropathic, diabetic foot ulcers.
Phase of Trial: Phase II
Latest Information Update: 31 May 2012
At a glance
- Drugs Sonedenoson (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors King Pharmaceuticals Research and Development
- 30 Jan 2008 Actual patient number 322 added as reported by ClinicalTrials.gov.
- 30 Jan 2008 Status change from in progress to completed.
- 29 Aug 2007 Status change from recruiting to in progress.